| MOVICS: an R package for multi-omics integration and visualization in cancer subtyping X Lu, J Meng, Y Zhou, L Jiang, F Yan Bioinformatics 36 (22-23), 5539-5541, 2020 | 77 | 2020 |
| Immune response drives outcomes in prostate cancer: Implications for immunotherapy J Meng, Y Zhou, X Lu, Z Bian, Y Chen, J Zhou, L Zhang, Z Hao, M Zhang, ... Molecular oncology 15 (5), 1358-1375, 2021 | 55 | 2021 |
| The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer K Wang, J Luo, S Yeh, B You, J Meng, P Chang, Y Niu, G Li, C Lu, Y Zhu, ... Nature communications 11 (1), 2689, 2020 | 49 | 2020 |
| Rapamycin treatment dose‐dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell‐cycle‐associated CDK1/cyclin axis A Li, S Fan, Y Xu, J Meng, X Shen, J Mao, L Zhang, X Zhang, G Moeckel, ... Journal of cellular and molecular medicine 21 (8), 1619-1635, 2017 | 45 | 2017 |
| Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy J Meng, X Lu, Y Zhou, M Zhang, Q Ge, J Zhou, Z Hao, S Gao, F Yan, ... Molecular Therapy-Oncolytics 20, 410-421, 2021 | 43 | 2021 |
| Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD A Li, Y Xu, S Fan, J Meng, X Shen, Q Xiao, Y Li, L Zhang, X Zhang, G Wu, ... JCI insight 3 (5), 2018 | 41 | 2018 |
| The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer J Meng, Y Liu, S Guan, S Fan, J Zhou, M Zhang, C Liang Cancer medicine 8 (11), 5202-5213, 2019 | 40 | 2019 |
| Upregulation of long noncoding RNA TUG1 promotes bladder cancer cell proliferation, migration, and invasion by inhibiting miR-29c P Guo, G Zhang, J Meng, Q He, Z Li, Y Guan Oncology research 26 (7), 1083, 2018 | 39 | 2018 |
| Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis LG Zhang, J Chen, JL Meng, Y Zhang, Y Liu, CS Zhan, XG Chen, L Zhang, ... The Prostate 79 (12), 1466-1476, 2019 | 37 | 2019 |
| TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case–control studies J Meng, S Wang, M Zhang, S Fan, L Zhang, C Liang Bioscience reports 38 (6), BSR20181452, 2018 | 37 | 2018 |
| CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: a systematic review and meta-analysis S Fan, J Meng, L Zhang, X Zhang, C Liang Pathology-Research and Practice 215 (1), 151-158, 2019 | 33 | 2019 |
| Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR B You, Y Sun, J Luo, K Wang, Q Liu, R Fang, B Liu, F Chou, R Wang, ... Oncogene 40 (9), 1674-1689, 2021 | 30 | 2021 |
| Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to … X Lu, J Meng, L Su, L Jiang, H Wang, J Zhu, M Huang, W Cheng, L Xu, ... Clinical and translational medicine 11 (12), 2021 | 29 | 2021 |
| MnFe2O4 nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system L Zhang, PF Wei, YH Song, L Dong, YD Wu, ZY Hao, S Fan, S Tai, ... Biomaterials 216, 119248, 2019 | 27 | 2019 |
| Establishment of a prognosis prediction model based on pyroptosis-related signatures associated with the immune microenvironment and molecular heterogeneity in clear cell renal … A Jiang, J Meng, Y Bao, A Wang, W Gong, X Gan, J Wang, Y Bao, Z Wu, ... Frontiers in oncology 11, 755212, 2021 | 26 | 2021 |
| Genetic variants of DNA repair pathway genes on lung cancer risk W Li, M Zhang, C Huang, J Meng, X Yin, G Sun Pathology-Research and Practice 215 (10), 152548, 2019 | 26 | 2019 |
| Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer J Meng, X Lu, Y Zhou, M Zhang, L Gao, S Gao, F Yan, C Liang Journal of cellular and molecular medicine 24 (10), 5797-5810, 2020 | 25 | 2020 |
| Polymorphism of MMP-9 gene is not associated with the risk of urinary cancers: Evidence from an updated meta-analysis J Meng, S Wang, X Shen, Z Bai, Q Niu, D Ma, Y Xu, C Liang Pathology-Research and Practice 214 (12), 1966-1973, 2018 | 22 | 2018 |
| Ten‐Eleven translocation 1 promotes malignant progression of cholangiocarcinoma with Wild‐Type isocitrate dehydrogenase 1 X Bai, H Zhang, Y Zhou, K Nagaoka, J Meng, C Ji, D Liu, X Dong, K Cao, ... Hepatology 73 (5), 1747-1763, 2021 | 20 | 2021 |
| Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling Q Liu, B You, J Meng, CP Huang, G Dong, R Wang, F Chou, S Gao, ... Cancer Gene Therapy 29 (12), 1988-2000, 2022 | 18 | 2022 |
Ao LiDepartment of Pharmacology, Yale University School of MedicineVerified email at yale.edu
